The FDA has approved subcutaneous daratumumab and hyaluronidase-fihj (Darzalex Faspro) for use in patients with high-risk ...

An advanced practice provider (APP)-led peer review quality assurance (QA) committee was found to be feasible and identified ...

Integrative oncology is a patient-centered approach to cancer care that looks at the whole patient and combines their ...

Among lymphoma survivors experiencing chronic fatigue, a multidisciplinary intervention program has been found to have a ...

Imatinib (Gleevec) showed durable efficacy in advanced gastrointestinal stromal tumors (GIST), with complete response (CR) or complete resection yielding a twofold increase in median survival, ...

Sequencing treatment for patients with relapsed or refractory multiple myeloma depends on the patient’s disease and history, explained Lisa Hwa Christenson, DNP, APRN, CNP, associate professor of ...